Colloidal nanoparticles, such as
gold nanoparticles (AuNPs), are
promising materials for the delivery of hydrophilic drugs via the
pulmonary route. The inhaled nanoparticle drug carriers primarily
deposit in lung alveoli and interact with the alveolar surface known
as lung surfactants. Therefore, it is vital to understand the interactions
of nanocarriers with the surfactant layer. To understand the interactions
at the molecular level, here we simulated model lung surfactant monolayers
with phospholipid (PL)-wrapped AuNPs at the vacuum–water interface
using coarse-grained molecular dynamics simulations. The PL-wrapped
AuNPs quickly adsorbed into the surfactant layer, altered the structural
properties of the monolayer, and at high concentrations initiated
the compressed monolayer to collapse/buckle. Among the surfactant
monolayer lipid components, cholesterol adsorbed to the AuNPs preferentially
over PL species. The position of the adsorbed PL-AuNPs within the
monolayer, and subsequent monolayer perturbation, vary depending on
the monolayer phase, monolayer composition, and species of PL used
as a ligand. Information provided by these molecular dynamic simulations
helps to rationalize why some colloidal nanoparticles work better
as nanocarriers than others and aid the design of new ones, to avoid
biological toxicity and improve efficacy for pulmonary drug delivery.